Literature DB >> 8794391

Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system.

R E Sutton1, D R Littman.   

Abstract

Studies of human T-cell leukemia virus type 1 (HTLV-1) have been hampered by the difficulty of achieving high cell-free and cell-associated infectious titers. Current retroviral pseudotyping systems using the HTLV-1 envelope generate titers of less than 200 infectious particles per ml. We describe here an improved system for pseudotyping using a defective human immunodeficiency virus (HIV) type 1 genome in combination with HTLV-1 env in 293T producer cells. Introduction of additional copies of rev and treatment of cells with sodium butyrate resulted in a cell-associated titer of 10(5)/ml and cell-free titers of greater than 10(4)/ml . By using this system, we found that the host range of HTLV-1 is even greater than previously suspected. Earlier studies which assigned a chromosomal location for the HTLV-1 receptor may therefore reflect cell-to-cell variation in receptor number rather than the absolute presence or absence of a receptor. The generation of higher-titer HIV(HTLV-1) may facilitate identification of the cellular receptor and investigations of the pathophysiology of HTLV-1 infection.

Entities:  

Mesh:

Year:  1996        PMID: 8794391      PMCID: PMC190797     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Production of high-titer helper-free retroviruses by transient transfection.

Authors:  W S Pear; G P Nolan; M L Scott; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

2.  Effect of butyrate on the expression of microinjected or transfected genes.

Authors:  Z A Yuan; R R Hirschhorn; R Baserga
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

3.  Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate.

Authors:  C M Gorman; B H Howard; R Reeves
Journal:  Nucleic Acids Res       Date:  1983-11-11       Impact factor: 16.971

4.  Human T-cell leukemia virus type I: induction of syncytia and inhibition by patients' sera.

Authors:  K Nagy; P Clapham; R Cheingsong-Popov; R A Weiss
Journal:  Int J Cancer       Date:  1983-09-15       Impact factor: 7.396

5.  Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study.

Authors:  Y Hinuma; H Komoda; T Chosa; T Kondo; M Kohakura; T Takenaka; M Kikuchi; M Ichimaru; K Yunoki; I Sato; R Matsuo; Y Takiuchi; H Uchino; M Hanaoka
Journal:  Int J Cancer       Date:  1982-06-15       Impact factor: 7.396

6.  Isolation of HTLV derived from Japanese adult T-cell leukemia patients in human diploid fibroblast strain IMR90 and the biological characters of the infected cells.

Authors:  H Yoshikura; J Nishida; M Yoshida; Y Kitamura; F Takaku; S Ikeda
Journal:  Int J Cancer       Date:  1984-06-15       Impact factor: 7.396

7.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Infection of human endothelial cells by human T-cell leukemia virus type I.

Authors:  J A Hoxie; D M Matthews; D B Cines
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

9.  Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line.

Authors:  P Clapham; K Nagy; R Cheingsong-Popov; M Exley; R A Weiss
Journal:  Science       Date:  1983-12-09       Impact factor: 47.728

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  38 in total

Review 1.  Tetraspanins in viral infections: a fundamental role in viral biology?

Authors:  F Martin; D M Roth; D A Jans; C W Pouton; L J Partridge; P N Monk; G W Moseley
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Isolation and characterization of mouse-human microcell hybrid cell clones permissive for infectious HIV particle release.

Authors:  Ayse K Coskun; Marc van Maanen; David Janka; David Stockton; Pawel Stankiewicz; Pawel Stankiewicsz; Svetlana Yatsenko; Richard E Sutton
Journal:  Virology       Date:  2007-01-31       Impact factor: 3.616

3.  Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes.

Authors:  E J Park; L K Vujcic; R Anand; T S Theodore; G V Quinnan
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

4.  Transmission of human T-cell leukemia virus type 1 to mice.

Authors:  J Fang; S Kushida; R Feng; M Tanaka; T Kawamura; H Abe; N Maeda; M Onobori; M Hori; K Uchida; M Miwa
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.

Authors:  David Ghez; Yves Lepelletier; Sophie Lambert; Jean-Marie Fourneau; Vincent Blot; Sébastien Janvier; Bertrand Arnulf; Peter M van Endert; Nikolaus Heveker; Claudine Pique; Olivier Hermine
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells.

Authors:  Kathryn S Jones; Kazunori Fugo; Cari Petrow-Sadowski; Ying Huang; Daniel C Bertolette; Ivonne Lisinski; Samuel W Cushman; Steven Jacobson; Francis W Ruscetti
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

7.  Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells.

Authors:  Kathryn S Jones; Cari Petrow-Sadowski; Daniel C Bertolette; Ying Huang; Francis W Ruscetti
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells.

Authors:  R E Sutton; H T Wu; R Rigg; E Böhnlein; P O Brown
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Human chromosome 2 carries a gene required for production of infectious human immunodeficiency virus type 1.

Authors:  Ayse K Coskun; Marc van Maanen; Van Nguyen; Richard E Sutton
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

10.  Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo.

Authors:  Jean-Stéphane Gatot; Isabelle Callebaut; Carine Van Lint; Dominique Demonté; Pierre Kerkhofs; Daniel Portetelle; Arsène Burny; Luc Willems; Richard Kettmann
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.